Pharmacological Presbyopia Eye Drops: Pilocarpine Miosis Optics & Depth of Field Physics

Topical pharmacological presbyopia drops (e.g., Pilocarpine HCl 1.25%) do not restore crystalline lens elasticity. Instead, they act as optical aperture stops:

• Cholinergic stimulation of iris sphincter $M_3$ receptors causes pupillary miosis from $4.0\ \text{mm}$ to $1.5\text{--}2.0\ \text{mm}$.
• The reduced aperture blocks diverging marginal out-of-focus light rays, minimizing retinal circle of confusion size.

Geometric depth of field (DoF) is inversely proportional to entrance pupil diameter ($d$):

$$\text{DoF} \approx \frac{2 \cdot c}{d \cdot m}$$

Where $c$ is the retinal permissible circle of confusion ($0.005\text{--}0.008\ \text{mm}$) and $m$ is eye magnification.

Constricting pupil diameter from $4.0\ \text{mm}$ to $1.75\ \text{mm}$ expands depth of field from $\pm 0.35\ \text{D}$ ($0.70\ \text{D}$ total) to $\pm 0.85\ \text{D}$ ($1.70\ \text{D}$ total), providing $+1.00\ \text{D}$ of pseudo-accommodation without glasses.

Retinal illuminance ($T$, in Trolands) is proportional to pupil area ($T = L \times A$). Shrinking the pupil from $4.0\ \text{mm}$ to $1.8\ \text{mm}$ reduces light flux reaching photoreceptors by 80%, causing profound night vision dimming and mesopic contrast loss.

Furthermore, if miosis constricts below $1.2\ \text{mm}$, Fraunhofer diffraction ($\theta_{\text{Airy}} = 1.22 \lambda / d$) broadens the central Airy disk, degrading visual acuity.